AbbVie Inc.
Company Snapshot
Founded: 2013
Entity Type: Public
Employees: 55,000
Region: U.S.
Revenue: $56,334.0 Millions
Revenue Year: 2024
Segment: Hematologic Oncology, Neuroscience, and Eye Care
Headquarter: North Chicago, Illinois, U.S.
Key Geographics: U.S., Europe, Asia-Pacific
Company Overview
AbbVie Inc. is a major pharmaceutical company that offers immunology, hematologic oncology, neuroscience, aesthetics, and eye care products. AbbVie maintains an extensive immunology portfolio across rheumatology, dermatology, and gastroenterology. The company operates in over 70 countries and markets its products in over 175 countries.
AbbVie has more than 250 collaborations/partnerships with leading biotechnology companies, universities, nonprofits, and government organizations to advance science. The company specializes in monoclonal antibodies, antibody-drug conjugates, and multi-specific antibodies for antibody therapeutics.
Financial Highlights (FY 2023)
Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***
This information is available for BCC Research members only.
AbbVie Inc. In News
Applications/End User Industries
- Healthcare Providers
- Hospitals
- Pharmacies
- Patients
- Governments
- Pharmaceutical
BCC Research Beacon 